Zejia Yang

发表

Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.

C. Rudin, L. Schumaker, E. Zuhowski, 2003, Cancer research.

Cisplatin Resistance Inhibition of Glutathione Synthesis Reverses Bcl-2-mediated Updated Version Cited Articles Citing Articles E-mail Alerts Inhibition of Glutathione Synthesis Reverses Bcl-2-mediated Cisplatin Resistance We Tested This Hypothesis Using Mcf-7 Breast Cancer Cells Transfected with th

C. Rudin, L. Schumaker, E. Zuhowski, 2022 .

Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines

P. Andrews, C. D. Ellison, K. Cullen, 2000, Cancer Chemotherapy and Pharmacology.

Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.

Daria A. Gaykalova, R. Mehra, L. Schumaker, 2022, Oral oncology.

Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer

Zhongmin Guo, L. Schumaker, K. Cullen, 2007, Journal of bioenergetics and biomembranes.

A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-κB regulates head and neck squamous cell carcinoma proliferation

A. Passaniti, Han C. Dan, Xuefeng Liu, 2016, Oncotarget.

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway

Han C. Dan, Jipei Liao, K. Cullen, 2019, BMC Cancer.

Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma

Han C. Dan, Jipei Liao, K. Cullen, 2020, Cell Death Discovery.

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway

Han C. Dan, Jipei Liao, K. Cullen, 2019, BMC Cancer.

IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer.

Han C. Dan, Xuefeng Liu, K. Cullen, 2015, American journal of cancer research.

Cisplatin Preferentially Binds Mitochondrial DNA and Voltage-Dependent Anion Channel Protein in the Mitochondrial Membrane of Head and Neck Squamous Cell Carcinoma: Possible Role in Apoptosis

Zhongmin Guo, L. Schumaker, E. Zuhowski, 2006, Clinical Cancer Research.

Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitor.

Han C. Dan, Jipei Liao, Long Chen, 2019, American journal of cancer research.

Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition

Han C. Dan, B. Kallakury, Xuefeng Liu, 2020, Clinical & Experimental Metastasis.

Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma

R. Mehra, Han C. Dan, Jipei Liao, 2022, Cancer Chemotherapy and Pharmacology.

Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition

Han C. Dan, B. Kallakury, Xuefeng Liu, 2020, Clinical & Experimental Metastasis.

Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer

Han C. Dan, Xuefeng Liu, Jipei Liao, 2018, British Journal of Cancer.

Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma

Han C. Dan, Jipei Liao, K. Cullen, 2020, Cell Death Discovery.

Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer

Han C. Dan, Xuefeng Liu, Jipei Liao, 2018, British Journal of Cancer.

Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.

M. Ellis, A. Pearce, M. Lippman, 1996, Molecular endocrinology.

Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co‐targeting EGFR and PI3K in cisplatin‐resistant HNSCC

Jipei Liao, Zejia Yang, Shirin Abarzarzin, 2024, Head & neck.